96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial

- Farrell, Michael, Shahbazi, Jeyran, Nielsen, Suzanne, Dunlop, Adrian, Dore, Gregory J., McDonough, Michael, Montebello, Mark, Weiss, Rob, Rodgers, Craig, Cook, Jon, Degenhardt, Louisa, Chambers, Mark, Byrne, Marianne, Gholami, Jaleh, Zahra, Emma, Grebely, Jason, Lintzeris, Nicholas, Larance, Briony, Ali, Robert

Acute experimental pain responses in methadone- and buprenorphine/naloxone-maintained patients administered additional opioid or gabapentin: a double-blind crossover pilot study

- Murnion, Bridin Patricia, Rivas, Consuelo, Demirkol, Apo, Hayes, Vicky, Lintzeris, Nicholas, Nielsen, Suzanne

An evaluation of the prescription of opioids for chronic nonmalignant pain by Australian general practitioners

- Holliday, Simon, Magin, Parker, Dunbabin, Janet, Oldmeadow, Christopher, Henry, Julie-Marie, Lintzeris, Nicholas, Attia, John, Goode, Susan, Dunlop, Adrian

An examination of the influences on New South Wales general practitioners regarding the provision of opioid substitution therapy

- Holliday, Simon, Magin, Parker, Oldmeadow, Christopher, Attia, John, Dunbabin, Janet, Henry, Julie-Marie, Lintzeris, Nicholas, Goode, Susan, Dunlop, Adrian

Assessing the concurrent validity, inter-rater reliability and test-re-test reliability of the Australian Treatment Outcomes Profile (ATOP) in alcohol and opioid treatment populations

- Deacon, Rachel M., Mammen, Kristie, Bruno, Raimondo, Mills, Llewellyn, Dunlop, Adrian, Holmes, Jennifer, Jefferies, Meryem, Hall, Michelle, Shakeshaft, Anthony, Farrell, Michael, Graham, Robert, Lintzeris, Nicholas

Assessing the validity of the Australian treatment outcomes profile for telephone administration in drug health treatment populations

- Deacon, Rachel M., Mammen, Kristie, Holmes, Jennifer, Dunlop, Adrian, Bruno, Raimondo, Mills, Llewellyn, Graham, Robert, Lintzeris, Nicholas

Cannabis use in patients 3 months after ceasing nabiximols for the treatment of cannabis dependence: results from a placebo-controlled randomised trial

- Lintzeris, Nicholas, Mills, Llewellyn, Kevin, Richard, Bhardwaj, Anjali, Dunlop, Adrian, Copeland, Jan, Mcgregor, Iain, Bruno, Raimondo, Kirby, Adrienne, Montebello, Mark, Hall, Michelle, Jefferies, Meryem

Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic

- Dunlop, Adrian, Lokuge, Buddhima, Masters, Debbie, Sequeira, Marcia, Saul, Peter, Dunlop, Grace, Ryan, John, Hall, Michelle, Ezard, Nadine, Haber, Paul, Lintzeris, Nicholas, Maher, Lisa

Comparing treatment-seeking codeine users and strong opioid users: findings from a novel case series

- Nielsen, Suzanne, Murnion, Bridin, Dunlop, Adrian, Degenhardt, Louisa, Demirkol, Apo, Muhleisen, Peter, Lintzeris, Nicholas

Correlates of pain in an in-treatment sample of opioid-dependent people

- Nielsen, Suzanne, Larance, Briony, Lintzeris, Nicholas, Black, Emma, Bruno, Raimondo, Murnion, Bridin, Dunlop, Adrian, Degenhardt, Louisa

Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder

- Mills, Llewellyn, Dunlop, Adrian, Montebello, Mark, Copeland, Jan, Bruno, Raimondo, Jefferies, Meryem, Mcgregor, Iain, Lintzeris, Nicholas

Determining clinical cutoff scores for the Australian Treatment Outcomes Profile psychological health, physical health and quality of life questions

- Mammen, Kristie, Mills, Llewellyn, Deacon, Rachel M., Bruno, Raimondo, Dunlop, Adrian, Holmes, Jennifer, Luksza, Jennifer, Shakeshaft, Anthony, Farrell, Michael, Lintzeris, Nicholas

Development of a brief tool for monitoring aberrant behaviours among patients receiving long-term opioid therapy: the Opioid-Related Behaviours In Treatment (ORBIT) scale

- Larance, Briony, Bruno, Raimondo, Mattick, Richard P., Lintzeris, Nicholas, Degenhardt, Louise, Black, Emma, Brown, Amanda, Nielsen, Suzanne, Dunlop, Adrian, Holland, Rohan, Cohen, Milton

Effectiveness and cost-effectiveness of unsupervised buprenorphine-naloxone for the treatment of heroin dependence in a randomized waitlist controlled trial

- Dunlop, Adrian J., Dunlop, AJ, Brown, AL, Oldmeadow, C, Attia, J, Harris, A, Ghijben, P, Sadler, C, Bell, J, Lintzeris, N, Brown, Amanda L., Hinman, Jennifer, Jackson, Melissa, Bell, James, Lintzeris, Nicholas, Oldmeadow, Christopher, Harris, Anthony, Gill, Anthony, Sadler, Craig, Ribbons, Karen, Attia, John, Barker, Daniel, Ghijben, Peter

Forming a national multicentre collaboration to conduct clinical trials: increasing high-quality research in the drug and alcohol field

- Sanson-Fisher, Rob, Brand, Matthew, Shakeshaft, Anthony, Haber, Paul, Day, Carolyn, Conigrave, Katherine, Mattick, Richard, Lintzeris, Nicholas, Teesson, Maree

Health and Social Characteristics of Clients Reporting Amphetamine Type Substance Use at Entry to Public Alcohol and Other Drug Services in New South Wales, Australia, 2016–2019

- Black, Emma, Mammen, Kristie, Shakeshaft, Anthony, Siefried, Krista J., Farrell, Michael, Holmes, Jennifer, Lintzeris, Nicholas, Deacon, Rachel M., Ezard, Nadine, Mills, Llewellyn, Dunlop, Adrian J., Montebello, Mark, Reid, David, Childs, Steven, Bruno, Raimondo

Lisdexamfetamine for the treatment of acute methamphetamine withdrawal: A pilot feasibility and safety trial

- Acheson, Liam S., Ezard, Nadine, Shoptaw, Steve, Siefried, Krista J., Lintzeris, Nicholas, Dunlop, Adrian, Brett, Jonathan, Rodgers, Craig, Gill, Anthony, Christmass, Michael, McKetin, Rebecca, Farrell, Michael

Long-term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult out-patients with opioid use disorder

- Frost, Michael, Bailey, Genie L., Oosman, Sonia, Kim, Sonnie, Tiberg, Fredrik, Lintzeris, Nicholas, Strang, John, Dunlop, Adrian, Nunes, Edward V., Jansen, Jakob Billeskov, Frey, Lars Chemnitz, Weber, Bernd, Haber, Pauk

Mood, sleep and pain comorbidity outcomes in cannabis dependent patients: Findings from a nabiximols versus placebo randomised controlled trial

- Montebello, Mark, Jefferies, Meryem, Lintzeris, Nicholas, Agonist Replacement For Cannabis Dependence Study Group (ARC-D),, Mills, Llewellyn, Bruno, Raimondo, Copeland, Jan, McGregor, Iain, Rivas, Consuelo, Jackson, Melissa A., Silsbury, Catherine, Dunlop, Adrian

Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial

- Allsop, David J., Copeland, Jan, Booth, Jessica, McGregor, Iain S., Lintzeris, Nicholas, Dunlop, Adrian J., Montebello, Mark, Sadler, Craig, Rivas, Gonzalo R., Holland, Rohan M., Muhleisen, Peter, Norberg, Melissa M.